J Physiol Pharmacol 60(Suppl 7):191196 Callahan CM, Apostolova LG, Gao S, Risacher SL, Case J, Saykin AJ, Lane KA, Swinford CG, Yoder MC (2020) Novel markers of angiogenesis in the setting of cognitive impairment and dementia
The clinical significance of understanding these peptides lies in their potential to address pathological conditions where conventional therapies may demonstrate limited efficacy
However, complete recovery may take several months, particularly if the deficiency has been present for a long time
Pregnant or breastfeeding women should avoid MOTS-c given the absence of safety data in these populations, as is standard for all investigational peptide therapies
See the clinical evidence for and against OmegaXL for reducing joint and muscle pain, plus safety and side effects, in our article about OmegaXL